Methyl iodide → N-({(5S)-3-[4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
反応式
[CH2:1]1COCC1.C[O:7][C:8]1[CH:13]=[C:12]([C:14]2[CH:19]=[CH:18][C:17]([N:20]3[CH2:24][C@H:23]([CH2:25][NH:26][C:27](=[O:29])[CH3:28])[O:22][C:21]3=[O:30])=[CH:16][CH:15]=2)[CH:11]=[CH:10][N:9]=1.C(=O)([O-])[O-].[K+].[K+].CI>C(Cl)Cl>[CH3:1][N:9]1[CH:10]=[CH:11][C:12]([C:14]2[CH:15]=[CH:16][C:17]([N:20]3[CH2:24][C@H:23]([CH2:25][NH:26][C:27](=[O:29])[CH3:28])[O:22][C:21]3=[O:30])=[CH:18][CH:19]=2)=[CH:13][C:8]1=[O:7]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 85 °C
実験手順
To a stirred anhydrous THF (10 mL) mixture of N-({(5S)-3-[4-(2-methoxypyridin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide (0.667 g, 1.95 mmol) in a sealed tube, is added potassium carbonate (0.807 g, 6.0 mmol) and methyl iodide (1 mL, 17 mmol). The mixture is heated to 85° C. for 16 hours. The reaction is cooled to RT and diluted to 300 mL with CH2Cl2. The K2CO3 is filtered. The solution is concentrated to dryness, dissolved in MeOH (20 mL) and treated with saturated Na2S2O3. The solution is concentrated to dryness on silica. The residue is loaded onto a SIM and purified on a Biotage 12M column with 2–4% MeOH in CH2Cl2 to yield the desired compound (0.460 g, 69%). 1H-NMR (DMSO) δ: 8.26, 7.77, 7.64, 6.68, 6.60, 4.74, 4.17, 3.78, 3.43, 1.83
後処理
- temperatureThe reaction is cooled to RT
- filtrationThe K2CO3 is filtered
- concentrationThe solution is concentrated to dryness
- dissolutiondissolved in MeOH (20 mL)
- additiontreated with saturated Na2S2O3
- concentrationThe solution is concentrated to dryness on silica
- custompurified on a Biotage 12M column with 2–4% MeOH in CH2Cl2
出典と根拠
- ORDレコード
- ord-68f084637a2845fca977375ed451ee03
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07094900B2
反応ノート
読み込み中…